Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID‐19: A Large Case‐Control Study

This study aimed to investigate whether specific medications used in the treatment chronic diseases affected either the development and/ or severity of coronavirus disease 2019 (COVID‐19) in a cohort of 610 COVID‐19 cases and 48,667 population‐based controls from Zhejiang, China. Using a cohort of 5...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacology and therapeutics 2020-12, Vol.108 (6), p.1185-1194
Hauptverfasser:	Yan, Huadong, Valdes, Ana M., Vijay, Amrita, Wang, Shanbo, Liang, Lili, Yang, Shiqing, Wang, Hongxia, Tan, Xiaoyan, Du, Jingyuan, Jin, Susu, Huang, Kecheng, Jiang, Fanrong, Zhang, Shun, Zheng, Nanhong, Hu, Yaoren, Cai, Ting, Aithal, Guruprasad P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - therapeutic use Calcium Channel Blockers - therapeutic use Cardiovascular Agents - therapeutic use Case-Control Studies Comorbidity COVID-19 - epidemiology Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Humans Hypertension - drug therapy Hypertension - epidemiology Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Middle Aged Risk Factors SARS-CoV-2 Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!